Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cells|May 13, 2026
Hapten-Based Cancer Immunotherapy: From Immune Activation to Antitumor ActivityIseulys Richert, Lionel Chalus, Benoit Pinteur, et al.
Journal of Bone Oncology|April 11, 2020
Corrigendum to: ``The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target.'' J Bone Oncol. 2020 Feb; 20: 100271Iseulys Richert, Anne Gomez-Brouchet, Corinne Bouvier, et al.
Oncoimmunology|March 28, 2017
Description of the immune microenvironment of chondrosarcoma and contribution to progressionFrançois A Simard, Iseulys Richert, Alexandra Vandermoeten, et al.
Cancers|September 28, 2023
A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 MacrophagesIseulys Richert, Paul Berchard, Lhorra Abbes, et al.
Pageof 1